MANE 8-K 2026-11-10
Veradermics, Inc (MANE) 8-K dated 2026-11-10 — accession 0001827635-26-000041.
Veradermics, Inc (MANE) common stock.
MANE: Veradermics Reports Third Quarter 2026 Financial Results and Highlights…
This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Income-statement cache for MANE is thin on this filing URL. We will not invent exhibit numbers.
Not investment advice. The MANE SEC hub lists recent forms. The stock page is the research view.
- Guidance
- expects to report topline data in the first half of 2027.
Why it matters
- expects to report topline data in the first half of 2027.